Jul 13, 2024, 05:22
2024 Equity in Access Research Program Grantees of The Leukemia and Lymphoma Society
The Leukemia and Lymphoma Society shared on X:
“Let’s applaud our 2024 Equity in Access Research Program Grantees! We’ve awarded nearly $6.5M to address barriers to blood cancer treatment & care that may lead to better health outcomes – supported by Royalty Pharma & Astra Zeneca. Discover more about our grantees & their work.”
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 27, 2024, 08:36
Oct 27, 2024, 08:32
Oct 27, 2024, 08:31
Oct 27, 2024, 08:26
Oct 27, 2024, 08:23
Oct 27, 2024, 08:23
Oct 27, 2024, 08:12
Oct 27, 2024, 08:05
Oct 27, 2024, 07:53